Xanomeline and trospium chloride (KarXT): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
Conditions studied
17
US states with sites
1
Countries
Phase breakdown
Phase 1 1
Phase 2 1
Not applicable 1
Conditions being studied
| Condition | Trials |
|---|---|
| Schizophrenia | 2 |
| SCHIZOPHRENIA 1 (Disorder) | 1 |
| Schizoaffecitve Disorder | 1 |
Recruiting trials involving Xanomeline and trospium chloride (KarXT)
- A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
- Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Common questions
How many recruiting trials involve Xanomeline and trospium chloride (KarXT)?
2 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.